Advertisement

Oncology

Resource Center

Featured

FDA Alert
FDA Alert
04/22/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA previously approved lisocabtagene maraleucel as a second-line treatment option for adult patients with large B-cell lymphoma in June 2022.
04/22/2024
Photoclinic
Photoclinic
04/16/2024

Kent Axcell, BS1• Yesul Kim, MD2Edward J. Fox, MD3Joseph J. Drabick, MD4Bryan E. Anderson, MD2

Kent Axcell, BS1• Yesul Kim, MD2• Edward J. Fox, MD3• Joseph J. Drabick, MD4• Bryan E. ...
A 60-year-old man presented to the emergency room with a left upper extremity angiosarcoma secondary to chronic lymphedema of the left upper extremity.
04/16/2024
Poll
Poll
04/11/2024
While most cases of chronic lymphocytic leukemia are appropriately managed with medication therapy, rare cases require the use of additional treatment modalities. Which of these other treatments have you...
04/11/2024
Advertisement

Interactive Features

Poll
Poll
04/11/2024
While most cases of chronic lymphocytic leukemia are appropriately managed with medication therapy, rare cases require the use of additional treatment modalities. Which of these other treatments have you...
04/11/2024
pop quiz
doctor lab coat
pop quiz
04/04/2024
Radiation therapy is considered a first-line treatment for uveal melanoma. Are you familiar with what type of radiation therapy is recommended for primary therapy in most cases of uveal melanoma?
04/04/2024
Pop Quiz
doctor and patient
Pop Quiz
03/30/2024
Disease risk stratification is essential to establishing an appropriate course of treatment in individuals with newly diagnosed prostate cancer. Are you familiar with the latest guidelines by the American...
03/30/2024
Pop Quiz
Pop Quiz
03/22/2024
A population-based, cross-sectional study found that the incidence of primary invasive breast cancer among younger women significantly increased after 2016.
03/22/2024
pop quiz
girl's eye
pop quiz
03/13/2024
Malignancy in uveal melanoma is often localized to one area of the eye. Do you know which region of the eye most cases are localized to? Take this pop quiz to find out.
03/13/2024

Clinical Insights

Video
Video
04/08/2024

Diana Abbott, PhD  Grace Bosma, MS

Diana Abbott, PhD • Grace Bosma, MS
In this video, Diana Abbott, PhD, and Grace Bosma, MS, discuss their team’s study on the outcomes and intensity of first-line therapy for the treatment of diffuse large B-cell lymphoma (DLBCL) in elderly...
04/08/2024
expert Q&A
expert Q&A
04/04/2024
In this expert Q&A, Mats Enlund, MD, PhD, discusses his team's study that adds to the growing literature on the impact of general anesthesia choice on overall survival among patients undergoing breast...
04/04/2024
Video
Video
03/31/2024

Jeffrey A. Sparks, MD MMSc

Jeffrey A. Sparks, MD MMSc
In this video, Jeffrey A. Sparks, MD, MMSc, discusses his study that evaluated the outcomes of patients with pre-existing rheumatoid arthritis (RA) who initiated immune checkpoint inhibitors for cancer, if...
03/31/2024
Conference Coverage
Conference Coverage
03/27/2024

Paulina J. Haight, MD

Paulina J. Haight, MD
In this video, Paulina Haight, MD, talks about her team's study where they sought to determine the association between platinum-free interval and the response to subsequent treatment for patients with...
03/27/2024
Conference Coverage
Conference Coverage
03/21/2024

Anna Jo Smith, MD, MPH, MSc

Anna Jo Smith, MD, MPH, MSc
In this video, Anna Jo Smith, MD, MPH, MSc, discusses the use of two FDA-approved immunotherapy treatments for endometrial cancer in patients. She talks about health care disparities surrounding the...
03/21/2024